Zolbetuximab + CAPOX in 1L claudin-18.2+(CLDN18.2+)/HER22locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.
Rui-hua Xu,Kohei Shitara,Jaffer A. Ajani,Yung-Jue Bang,Peter C. Enzinger,David H. Ilson,Florian Lordick,Eric Van Cutsem,Javier Gallego Plazas,Jing Huang,Lin Shen,Sang Cheul Oh,Patrapim Sunpaweravong, Hwoei Fen Soo Hoo,Haci M. Turk,Jung Wook Park,Diarmuid Martin Moran, Pranob P. Bhattacharya,Ahsan Arozullah,Manish A. Shah JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
